| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 49.70B | 54.28B | 52.20B | 66.90B | 46.36B |
| Gross Profit | 5.20B | 5.63B | 6.16B | 11.36B | 5.74B |
| EBITDA | 9.82B | 9.56B | 10.23B | 13.90B | 6.66B |
| Net Income | 3.93B | 3.14B | 4.11B | 6.45B | 587.00M |
Balance Sheet | |||||
| Total Assets | 63.42B | 56.54B | 53.91B | 55.87B | 54.10B |
| Cash, Cash Equivalents and Short-Term Investments | 2.74B | 3.09B | 2.23B | 4.52B | 2.87B |
| Total Debt | 17.01B | 10.63B | 9.95B | 11.64B | 15.42B |
| Total Liabilities | 31.79B | 26.77B | 25.20B | 28.28B | 30.50B |
| Stockholders Equity | 31.62B | 29.75B | 28.70B | 27.58B | 23.60B |
Cash Flow | |||||
| Free Cash Flow | 3.41B | 4.22B | 3.09B | 7.64B | 3.36B |
| Operating Cash Flow | 8.23B | 9.23B | 7.39B | 11.40B | 5.92B |
| Investing Cash Flow | -7.68B | -5.13B | -5.29B | -2.31B | -942.00M |
| Financing Cash Flow | -749.00M | -3.50B | -4.31B | -7.68B | -2.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | C$87.85B | 18.28 | 14.75% | 2.45% | -6.18% | -14.06% | |
75 Outperform | C$36.08B | 17.93 | 9.91% | 5.44% | 2.81% | -14.92% | |
74 Outperform | C$108.86B | 12.55 | 13.17% | 3.91% | -3.08% | -31.48% | |
73 Outperform | C$69.55B | 10.69 | 13.16% | 3.40% | -9.17% | -12.97% | |
69 Neutral | C$91.79B | 22.34 | 12.80% | 4.41% | -3.98% | -33.45% | |
69 Neutral | C$24.89B | 89.45 | 8.69% | 4.79% | 8.97% | -21.15% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% |